Epidemiological study showed that the polymorphism at the –45 locus of CCK promoter is significantly different not only between PD and healthy controls, but also between treated PD patients with hallucination and those without in Japanese population (Fujii et al., 1999). This evidence concerns the gene CCK and Parkinson disease.